University Hospital Centre Zagreb

Futó vizsgálatok

• Toboroz

  A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

  NCT07444450· 3. fázis· Biogen· Forrás

• Még nem toboroz

  A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus

  NCT07606521· 1. fázis· Polpharma Biologics International AG· Forrás

• Toboroz

  Intracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation

  NCT07772518· Mitera Hospital· Forrás

• Még nem toboroz

  A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer

  NCT07340658· 3. fázis· Rovi Pharmaceuticals Laboratories· Forrás

• Toboroz

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  2025-524404-29-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  OPTION-EMEA Clinical Trial

  NCT07349121· Boston Scientific Corporation· Forrás

• Meghívásos bevonás

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· 2. fázis· Spyre Therapeutics, Inc.· Forrás

• Még nem toboroz

  HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before

  2025-524230-25-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

  NCT07637266· Klinički Bolnički Centar Zagreb· Forrás

• Toboroz

  A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease

  2025-522001-38-00· 2. fázis· Mirador Therapeutics Inc.· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT07218341· 4. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás

• Toboroz

  A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  NCT06937229· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  NCT07227402· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· AbbVie· Forrás

• Toboroz

  A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

  NCT06865417· 3. fázis· Alfasigma S.p.A.· Forrás

• Toboroz

  A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)

  2024-518296-56-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

  NCT06784466· Arga Medtech SA· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  NCT06976216· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease

  2024-513035-25-00· 2. fázis· Intra-Cellular Therapies Inc.· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· 3. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

  NCT07211633· 3. fázis· TG Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

  NCT06880744· 3. fázis· AbbVie· Forrás

• Toboroz

  A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis

  2024-511458-32-00· 3. fázis· Alfasigma S.p.A.· Forrás

• Fut, nem toboroz

  Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

  NCT06847724· 3. fázis· Sandoz· Forrás

• Toboroz

  Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke

  NCT07232498· Unidade Local de Saúde de Coimbra, EPE· Forrás

• Toboroz

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  NCT07012395· 2. fázis· Spyre Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

  NCT06940830· 4. fázis· Swedish Orphan Biovitrum· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819891· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

  NCT06929806· 3. fázis· Pharmacosmos A/S· Forrás

• Toboroz

  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  NCT06875310· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Toboroz

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· 3. fázis· Neurocrine Biosciences· Forrás

• Toboroz

  Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

  2024-511346-39-00· 1. fázis· Chugai Pharmaceutical Co. Ltd.· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  NCT06747949· 3. fázis· Amgen· Forrás

• Toboroz

  An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis

  2023-507853-13-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06786624· 3. fázis· Neurocrine Biosciences· Forrás

• Fut, nem toboroz

  Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  NCT06700343· 3. fázis· Amgen· Forrás

• Meghívásos bevonás

  Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

  NCT06723106· 1. fázis· Chugai Pharmaceutical· Forrás

• Toboroz

  ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia

  2024-513824-41-00· 4. fázis· Semmelweis University· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis

  2024-512707-40-00· 2. fázis· Zenas Biopharma (USA) LLC· Forrás

• Toboroz

  The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial

  NCT06929364· The Gut Microbiome Center (Centar za crijevni mikrobiom)· Forrás

• Fut, nem toboroz

  A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with Brentuximab Vedotin-ESHAP vs ESHAP in Patients with Relapsed / Refractory Classical Hodgkin’s Lymphoma, Followed by Brentuximab Vedotin Consolidation (instead of Autologous Hematopoietic Stem Cell Transplantation) in Those who Attained a Metabolic Complete Remission after Salvage Therapy

  NCT04378647· 2. fázis· Fundacion Geltamo· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

  NCT06651567· 2. fázis· Intra-Cellular Therapies, Inc.· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

  NCT06544499· 3. fázis· argenx· Forrás

Showing 50 of 123.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Colitis ulcerosa8 toboroz
• Hemofília8 toboroz
• Alzheimer-kór7 toboroz
• Crohn-betegség4 toboroz
• Pitvarfibrilláció4 toboroz
• Sclerosis multiplex (SM)4 toboroz
• Immune thrombocytopenia (ITP)3 toboroz
• Koszorúér-betegség3 toboroz
• Stroke (szélütés)3 toboroz
• Depresszió2 toboroz
• Dermatomyositis and polymyositis (myositis)2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Mielóma multiplex2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Szívelégtelenség2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Áttétes emlőrák1 toboroz
• Endometriózis1 toboroz
• Follikuláris limfóma1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Időskori makuladegeneráció1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Skizofrénia1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Tüdőrák1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Lezárult

  A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis

  NCT07222189· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· 3. fázis· Takeda· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis

  NCT06867094· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.

  NCT06637631· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Immutep S.A.S.· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· 3. fázis· Takeda· Forrás

• Lezárult

  A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania

  2024-513036-26-00· 3. fázis· Intra-Cellular Therapies Inc.· Forrás

• Fut, nem toboroz

  Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

  NCT06635824· 3. fázis· Genmab· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Fut, nem toboroz

  Phase IIa Study Evaluating AZD7798 in Crohn's Disease

  NCT06450197· 2. fázis· AstraZeneca· Forrás

• Meghívásos bevonás

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· 2. fázis· Biohaven Therapeutics Ltd.· Forrás

• Lezárult

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome

  2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

  NCT05813288· 3. fázis· Areteia Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Fut, nem toboroz

  Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

  NCT05853575· 2. fázis· Mirati Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma

  2023-503288-40-00· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

  NCT06141473· 3. fázis· Sanofi· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  Pulsed ElectRic FiEld Versus Cryoballoon for PAF

  NCT07100834· Universitair Ziekenhuis Brussel· Forrás

• Lezárult

  A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV Melanoma in the Adjuvant Setting

  2022-502620-49-00· 1. fázis· Amgen Inc.· Forrás

• Lezárult

  A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

  NCT05907122· 3. fázis· Amgen· Forrás

• Lezárult

  A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of Ascending Intravenous Doses of Glofitamab, Administered after Ocrelizumab Pretreatment, in Patients with Multiple Sclerosis

  2023-506863-32-00· 1. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa

  2022-502921-16-00· 4. fázis· Swedish Orphan Biovitrum AB (publ)· Forrás

• Lezárult

  A 24-month study evaluating physical activity and joint health in patients 12 years and older, with severe haemophilia A treated once weekly with efanesoctocog alfa.

  2022-500275-31-00· 3. fázis· Swedish Orphan Biovitrum AB (publ)· Forrás

• Lezárult

  Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO)

  2022-501586-50-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· 3. fázis· Amgen· Forrás

• Lezárult

  ASURE: Alzheimer Study Using oRal Edaravone

  NCT05323812· 2. fázis· Treeway B.V.· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· 3. fázis· Abivax S.A.· Forrás

• Fut, nem toboroz

  ABTECT - Maintenance

  NCT05535946· 3. fázis· Abivax S.A.· Forrás

• Fut, nem toboroz

  Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)

  NCT05429268· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· 3. fázis· AbbVie· Forrás

• Lezárult

  Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation

  NCT05572047· Arga Medtech SA· Forrás

• Lezárult

  A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

  NCT05415215· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

  NCT05115110· 2/3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· 3. fázis· Amgen· Forrás

• Lezárult

  A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study

  2024-511560-93-00· 3. fázis· Boehringer Ingelheim International GmbH· Forrás

• Toboroz

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· 3. fázis· Johnson & Johnson Enterprise Innovation Inc.· Forrás

• Lezárult

  Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

  NCT05110157· 3. fázis· Neurocrine Biosciences· Forrás

• Leállították

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· 3. fázis· InDex Pharmaceuticals· Forrás

• Leállították

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease

  2024-513569-38-00· 2/3. fázis· Arena Pharmaceuticals Inc.· Forrás

• Lezárult

  The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy

  NCT04636814· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

Showing 50 of 80.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Cushing's syndrome9 munka · 0 vizsgálat
• Familiáris hiperkoleszterinémia7 munka · 0 vizsgálat
• Hemofília6 munka · 15 vizsgálat
• Graves' disease and hyperthyroidism6 munka · 0 vizsgálat
• ANCA-asszociált vasculitis5 munka · 0 vizsgálat
• Magas vérnyomás5 munka · 2 vizsgálat
• Dermatomyositis and polymyositis (myositis)4 munka · 3 vizsgálat